Globally, 337,872 people were diagnosed with pancreatic cancer in 2012 and 330,372 died of this disease (Globocan, 2012). Pancreatic Cancer is the fourth leading cause of cancer deaths among female and males due to its low survival rates (Canadian Cancer Stats, 2014).
Pancreatic cancer starts in the pancreas, which is part of the digestive system and endocrine (hormone) system. Early detection means finding a cancer or precancerous condition at an early stage. In most cases, finding cancer early increases the chances of successful treatment (Canadian Cancer Society Cancer Encyclopedia).
For additional information about pancreatic cancer, please go to the Canadian Cancer Society Cancer Encyclopedia.
The Lustgarten Foundation aims to advance the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer by:
- Increasing funding and support of research into the biological mechanisms and clinical strategies related to the prevention, diagnosis, and treatment of pancreatic cancer;
- Facilitating and enhancing the dialogue among members of the medical and scientific communities about basic and clinical research efforts that relate to pancreatic cancer;
- Heightening public awareness of pancreatic cancer diagnosis, treatment, and prevention and providing informational support for pancreatic cancer patients, their families, and friends.
1111 Steward Avenue, Bethpage, New York 11714
The Pancreatic Cancer Action Network is a national network of people who are dedicated to advancing research, providing patient support, and creating hope for those affected by pancreatic cancer. The network raises funds for research and also advocates for federal research funding.
Pancreatic Cancer Action Network
1500 Rosecrans Avenue, Suite 200
Manhattan Beach, CA 90266
Toll Free: 877-272-6226
Pancreatic Cancer Action Network Japan (Tokyo Office)
Q-Dan 1991 Building 5F
1-12-1 Fujimi, Chiyodaku
Pancreatic Cancer UK provides easy access to the best and most up-to-date information on pancreatic cancer; runs discussion forums for pancreatic cancer patients, caregivers and families; provides individual support via email and telephone; and funds research.
2nd Floor, Camelford House
89 Albert Embankment
London SE1 7TW
Tel: +44 (0)20 3535 7090
The Rolfe Foundation serves as a catalyst for the early diagnosis and ultimate cure of pancreatic cancer by funding advanced medical research, public awareness initiatives, and educational programs. The Foundation also seeks to increase the quality and quantity of emotional and psychological support services for pancreatic cancer patients and their families through partnerships with organizations that specialize in this type of care.
Michael Rolfe Pancreatic Cancer Foundation
17 North State Street, Suite 1550
Chicago, Illinois 60602
The Pancreatic Cancer Alliance (PCA) has been a driving force for critical research, patient care and education at the University of Massachusetts Medical School and the UMass Memorial Cancer Center of Excellence. Founded in 2003, the alliance is made up of many dedicated and determined volunteers who have been affected by this devastating illness and who are motivated to change the course of this disease. They are current patients, caregivers, and medical professionals, as well as family members and friends of those claimed by pancreatic cancer, the 4th leading cause of cancer death in the United States.
The mission of PCA is to support the efforts of the medical and research communities at UMass Medical School and UMass Memorial Cancer Center of Excellence as well as patients and their loved ones in the battle against pancreatic cancer by:
- Increasing funding for research and the support of patients
- Intensifying our efforts to heighten public awareness of pancreatic cancer
- Helping to educate patients and medical professionals about pancreatic cancer
Facebook: Pancreatic Cancer Alliance
Pancreatic Cancer Research Fund is the national charity dedicated exclusively to supporting research to improve diagnosis and treatment of pancreatic cancer.
Pancreatic Cancer Research Fund has three main objectives:
- To raise funds for research into early detection, new treatments and ultimately a cure for pancreatic cancer
- To encourage more of the research community to get involved in pancreatic cancer research
- To promote the need for more research funding by the major cancer research funding organisations
- To date, Pancreatic Cancer Research Fund has supported 27 research projects with grants totalling £4 million – all through fundraising and donations.
Pancreatic Cancer Research Fund
PO Box 47432
Phone: 020 8360 1119